Junfen Xu

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 16

Top Topics

Long Noncoding Rna

Top Venues

Cancer metastasis reviews

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Cell death & disease

Cancer management and research

This page only lists publications with an associated author ORCID identifier.

Publications

Tianchen Guo, Junfen Xu
Cancer-associated fibroblasts: a versatile mediator in tumor progression, metastasis, and targeted therapy. Cancer metastasis reviews 43 (3) (2024)
Tingting Chen, Junfen Xu, Bairong Xia, Hui Wang, Yuanming Shen
Secondary cytoreduction surgery for recurrent epithelial ovarian cancer patients after PARPi maintenance: A multicenter, randomized, controlled clinical trial. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 34 (2) (2024)
Tianchen Guo, Junfen Xu
Cancer-associated fibroblasts: a versatile mediator in tumor progression, metastasis, and targeted therapy. Cancer metastasis reviews 43 (3) (2024)
Yongjie Huang, Xinyi Wei, Mengyan Tu, Wei-Guo Lv, Junfen Xu
CircMAN1A2_009 facilitates YBX1 nuclear localization to induce GLO1 activation for cervical adenocarcinoma cell growth. Cancer science (2024)
Tianchen Guo, Junfen Xu
Cancer-associated fibroblasts: a versatile mediator in tumor progression, metastasis, and targeted therapy. Cancer metastasis reviews (2024)
Tianchen Guo, Junfen Xu
Cancer-associated fibroblasts: a versatile mediator in tumor progression, metastasis, and targeted therapy. Cancer metastasis reviews 43 (3) (2024)
Tingting Chen, Junfen Xu, Bairong Xia, Hui Wang, Yuanming Shen
Evaluation of Secondary Cytoreduction Surgery in Platinum-Resistant Ovarian Cancer Patients Within Three-Line Recurrent: A Multicenter, Randomized Controlled Study. Journal of gynecologic oncology (2023)
Tingting Chen, Junfen Xu, Bairong Xia, Hui Wang, Yuanming Shen
Secondary cytoreduction surgery for recurrent epithelial ovarian cancer patients after PARPi maintenance: A multicenter, randomized, controlled clinical trial. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society (2023)
Junfen Xu, Yifeng Fang, Kelie Chen, Sen Li, Sangsang Tang, Yan Ren, Yixuan Cen, Weidong Fei, Bo Zhang, Yuanming Shen, Wei-Guo Lv
Single-Cell RNA Sequencing Reveals the Tissue Architecture in Human High-Grade Serous Ovarian Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (16) (2022)
Zhi Zheng, Xiaojing Chen, Xiaoyun Cai, Hui Lin, Junfen Xu, Xiaodong Cheng
RNA-binding protein MEX3D promotes cervical carcinoma tumorigenesis by destabilizing TSC22D1 mRNA. Cell death discovery 8 (1) (2022)
Yuanming Shen, Yan Ren, Kelie Chen, Yixuan Cen, Bo Zhang, Wei-Guo Lv, Junfen Xu
The impact of neoadjuvant chemotherapy on the tumor microenvironment in advanced high-grade serous carcinoma. Oncogenesis 11 (1) (2022)
Sangsang Tang, Yuanming Shen, Xinyi Wei, Zhangjin Shen, Wei-Guo Lv, Junfen Xu
Olaparib synergizes with arsenic trioxide by promoting apoptosis and ferroptosis in platinum-resistant ovarian cancer. Cell death & disease 13 (9) (2022)
Yixuan Cen, Yifeng Fang, Yan Ren, Shiyuan Hong, Wei-Guo Lv, Junfen Xu
Global characterization of extrachromosomal circular DNAs in advanced high grade serous ovarian cancer. Cell death & disease 13 (4) (2022)
Haibin Liu, Junfen Xu, Yanqin Yang, Xiaohong Wang, Ethan Wu, Vladimir Majerciak, Tingting Zhang, Renske D M Steenbergen, Hsu-Kun Wang, Nilam S Banerjee, Yang Li, Weiguo Lu, Craig Meyers, Jun Zhu, Xing Xie, Louise T Chow, Zhi-Ming Zheng
Oncogenic HPV promotes the expression of the long noncoding RNA lnc-FANCI-2 through E7 and YY1. Proceedings of the National Academy of Sciences of the United States of America 118 (3) (2021)
Shizhou Yang, Tingting Chen, Lu Huang, Shanshan Xu, Zhu Cao, Songfa Zhang, Junfen Xu, Yang Li, Yongfang Yue, Weiguo Lu, Xiaodong Cheng, Xing Xie
High-Risk Human Papillomavirus E7 Maintains Stemness Via APH1B In Cervical Cancer Stem-Cell Like Cells. Cancer management and research 11 (2019)
Junfen Xu, Shanshan Xu, Yifeng Fang, Tingting Chen, Xing Xie, Weiguo Lu
Cyclin-dependent kinase 9 promotes cervical cancer development via AKT2/p53 pathway. IUBMB life 71 (3) (2018)